Paul A. Grayson serves as Executive at Skye Bioscience, Inc., where they oversee executive responsibilities. Since joining the company, Paul A. Grayson has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 6, 2026 involved receiving (via award) 35,000 shares valued at $0.
Paul A. Grayson currently holds 35,000 shares of Skye Bioscience, Inc. (SKYE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul A. Grayson has been a net neutral trader of SKYE stock. They have purchased $0 and sold $0 worth of shares.
Paul A. Grayson's most recent insider trade was on Feb 6, 2026, when they sold 35,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 6, 2023 | SKYE | $0 | Award | 173,721 | $N/A | Discretionary |
| Aug 25, 2023 | SKYE | $0 | Award | 18,132,596 | $N/A | Discretionary |